Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,510.00
Bid: 12,524.00
Ask: 12,526.00
Change: 118.00 (0.95%)
Spread: 2.00 (0.016%)
Open: 12,468.00
High: 12,556.00
Low: 12,434.00
Prev. Close: 12,392.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-Europe's STOXX 600 marks third month of gains on earnings, recovery hopes

Fri, 30th Apr 2021 09:54

* AstraZeneca boosts UK's FTSE 100

* Barclays tumbles despite profit beat

* STOXX 600 chalks up 1.8% rise in April

* European economy dips into second technical recession in
Q1
(Updates to market close)

By Sruthi Shankar and Ambar Warrick

April 30 (Reuters) - European stocks ended lower on Friday
after dismal GDP data, but marked a third straight month of
gains on strong corporate earnings and optimism about an
economic recovery from the COVID-19 pandemic.

The pan-regional STOXX 600 index fell 0.3%,
hovering below its all-time high, and ending the month 1.8%
higher.

Data showed the euro zone economy dipped into a second
technical recession after a smaller than expected contraction in
the first quarter, but is now set for recovery as pandemic curbs
are lifted amid accelerating vaccination campaigns.

The German economy contracted by a greater-than-expected
1.7%, hit by renewed lockdowns, while the French economy grew
more than expected.

But strong earnings showed companies in the euro zone were
well on their way to recover from the impact of the pandemic.

AstraZeneca jumped 4.3% as the British drugmaker
posted better-than-expected results and forecast second half
growth.

Swedish Match rose 0.7% after the tobacco group
reported a much higher first-quarter operating profit than
expected, helped by growth in its Smokefree product segment. UK
peers British American Tobacco and Imperial Brands
rose more than 2% each.

Broadly, European earnings have come in much stronger than
expected, with a higher than usual 71% of companies beating
profit expectations in the first quarter, according to Refinitiv
IBES data. A third of STOXX 600 companies have published results
so far.

"Expectations are high, companies are beating even these
elevated expectations, and yet the market is responding with
caution," Lewis Grant, portfolio manager at Federated Hermes,
wrote in a note.

"At current valuations, and with much pandemic related
uncertainty remaining, many investors are more concerned about
downside than upside."

Strong earnings from British firms helped the European
retailers sector outpace its peers in April with a 6.7%
bounce, while automobile stocks lagged as a global
semiconductor shortage hurt production.

Banking stocks came under pressure on Friday as euro
zone bond yields eased from their highest level since January
2020. But the sector raced past its peers this week with a near
6% gain, driven by a swathe of strong earnings.

Barclays tumbled 7% despite reporting a quarterly
profit that more than doubled, while France's BNP Paribas
slipped 0.8% on higher costs.

Spain's Banco Sabadell jumped 8.7% to the top of
the STOXX 600 after its quarterly profit beat market
expectations, helped by strength in its British unit TSB.
(Reporting by Sruthi Shankar in Bengaluru; Editing by Shounak
Dasgupta and Mark Potter)

More News
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.